RxDoctor Payments Data

David Wight, MD

Psychiatry · Rockford, ILNPI 1740471317

Payments from drug & device makers

$405in general payments, 2019–2025

Across 31 payments — averaging $13.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$154
  • Takeda Pharmaceuticals U.S.A., Inc.$92
  • Lundbeck LLC$52
  • Shire North American Group Inc$46
  • AbbVie$35
  • Sunovion Pharmaceuticals Inc.$26

What the payments were for

  • Food & beverage$404100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$405 in reported general payments places this provider in the 60th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois

Medicare billing

Part B allowed, 2024
$58,256
Medicare patients
71
Services billed
566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate14$110,938
XanaxAlprazolam13$20,966
TrintellixVortioxetine Hydrobromide16$14,096
Vilazodone Hcl47$4,803
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine58$1,821
Atomoxetine Hcl12$1,464
Duloxetine Hcl135$1,296
Bupropion XlBupropion Hcl93$1,259
Alprazolam205$1,142
Fluoxetine Hcl88$1,131
Desvenlafaxine Succinate ErDesvenlafaxine Succinate21$1,042
Mirtazapine134$1,021
Bupropion Hcl SrBupropion Hcl39$881
Quetiapine Fumarate ErQuetiapine Fumarate13$852
Buspirone Hcl110$846

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$92$14,09616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,344 psychiatry providers in Illinois.

Other psychiatry in Rockford

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →